Navigation Links
Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training
Date:8/20/2007

ENGLEWOOD, Colo., Aug. 20 /PRNewswire/ -- Baxa Corporation has published the 2008 dates for training at its STAR (Skills Training, Academics and Resources) Center. The STAR Center, a premier facility designed for cleanroom and pharmacy practice demonstration, is located at the company's world headquarters south of Denver, Colorado. Baxa Corporation built the STAR Center to provide professional education on pharmacy practice, cleanroom principles and compliance to regulatory requirements.

Class dates for the Compliance Tools and Aseptic Certification for USP < 797 > Course are being announced now because classes through the remainder of 2007 have been sold out since June. Each class covers 2-1/2 days of hands-on and classroom training, for 21 hours of CE credit.

The first class will be held on January 22-24, with subsequent program dates March 18-20, April 22-24 and June 17-19. Classes are tentatively planned for July, August, October and November; however dates are subject to change. The ACPE-certified training is filled on a first come, first served basis. Attendance in the STAR Center classes is limited to 20 participants to ensure resource availability, student-teacher ratios and hands-on experiences in the cleanrooms.

Current programming targets pharmacy and IV managers, providing value for any personnel who compound sterile products or are implementing cleanroom principles and practices that comply with USP < 797 > and industry best practice. Course topics include cleanroom physical design and layout, engineering controls and airflow science, media fill testing and principles associated with work flow, staff training, cleaning, monitoring, validation and documentation.

Baxa Corporation sponsors the STAR Center to further best practices in hospital pharmacy. The STAR Center brings together professional and industry partners to provide participants with a range of experience in equipment, technology and design.

The STAR Center
'/>"/>

SOURCE Baxa Corporation

Copyright©2007 PR Newswire.

Page: 1 2 3

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...all/ - Vasogen Inc.,(NASDAQ: VSGN ; TSX:VAS) today...ructuring plans to further reduce its cash burn ra...exploring strategic alternatives that may,include ... with this,process, the Company has also completed...d has determined that it is in the best interest o...
(Date:7/3/2008)...y, July 3,/- Rosetta Genomi...croRNA-based diagnostics and therapeutics, announc...nual Growth Conference on,Wednesday, July 9, at 8:...rk., About Rosetta Genomics, Rosetta Genomics (N...A.,Founded in 2000, the company,s integrative rese...
(Date:7/2/2008)...briva Therapeutics, a,specialist in antibiotics de...s been appointed as Chief Executive Officer of the...ly twenty years of industry,experience serving mos...nt,Licensing & Strategy for the oncology business...ible for the full array of business development,ac...
(Date:7/2/2008)...nstrate Superiority Over,Market-Leading Stent in C... Treatment of Coronary Artery Dis...Call/ -- Abbott today,announced that the U.S. Food...(TM) V Everolimus Eluting Coronary Stent System fo... V is the only drug eluting stent to have,demonstr...
Breaking Biology Technology:Vasogen Provides Corporate Update 2Nabriva Therapeutics Announces Appointment of New CEO 2FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 2FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 3FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 4FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 5
...ternet access is now a reality for one rural Wisco...ss broadband system. Toronto-based WaveRider Comm...LVT Corp. and Oakdale Electric Cooperative to i...n. The city previously lacked access to broadband ...been tremendous, with many of the local businesses...
...lk at my local elementary school given by Peter Se...t proponent of systems thinking. Systems thinking ...ool set developed over the past fifty years, to tr...s and interrelationships clearer, and to help see ...sence of systems thinking lies in a shift of minds...
...al dilemmas posed by the emergence of new abilitie...osition to disease will be the focus of the Third ...3. , ,The forum - titled "Who Knows? Who Should Kn...ll be held at Promega Corporation,s BioPharmaceuti...ent, moderated by Todd McVey of HospiceCare, Inc.,...
... savvy marketers enjoy cyber-branding using Netwo...omain name for an entire century. , ,Wow, its the...ight now its the cheapest license in the world, pr...he only gateway to your Web sites and the only key... Right now global cyber-branding is the only game ...
Other Biology Technology:Rural Wisconsin town gets high-speed Internet access 2Outsourcing: Net gain or shifting the pain? 2Outsourcing: Net gain or shifting the pain? 3Annual Bioethics Forum to explore genetic testing 2Why not brand for an entire century? 2Why not brand for an entire century? 3Why not brand for an entire century? 4
(Date:7/3/2008)...ncestors of such marine creatures as clams, sand d...nning 144 million years ago with no clear trend af...searchers. This contradicts previous work showing ... and may shed light on future diversity., "Some ...what is happening today from global warming," says...
(Date:7/3/2008)...ting your imagination run away with you may actual...rom Vanderbilt University has found that mental im... impacts our visual perception. , The research ...nt Biology . , "We found that imagery leads to a...eption," Joel Pearson, research associate in the V...
(Date:7/3/2008)...vid Geffen School of Medicine at UCLA have solved ...um glucose co-transporters (SGLTs), which pump glu... in the treatment of chronic diarrhea via oral reh...children each year. The solution of the SGLT struc...gned to treat patients with diabetes and cancer. ...
(Date:7/3/2008)...08) -- There,s little the average person can do to...tural gas and other energy sources. But by improvi...at work, we can use less energy and save money. ,...pted on 20 June, says that, "Through energy effici...ergy costs; reduce the depletion of fuel resources...
Breaking Biology News(10 mins):Ancient marine invertebrate diversity less explosive than thought 2Ancient marine invertebrate diversity less explosive than thought 3'Mind's eye' influences visual perception 2'Mind's eye' influences visual perception 3UCLA researchers clarify function of glucose transport molecule 2IEEE-USA position encourages energy efficiency to save households money, reduce carbon emissions 2NASA Releases Findings of Astronaut Survey 9909 1Governor Rendell Offers Coverage to 29 000 on AdultBasic Waiting List 3B Unveils New Policy to Improve Quality of Care for the Low Income and Pennsylv 9904 1Governor Rendell Offers Coverage to 29 000 on AdultBasic Waiting List 3B Unveils New Policy to Improve Quality of Care for the Low Income and Pennsylv 9904 2Governor Rendell Offers Coverage to 29 000 on AdultBasic Waiting List 3B Unveils New Policy to Improve Quality of Care for the Low Income and Pennsylv 9904 3Governor Rendell Offers Coverage to 29 000 on AdultBasic Waiting List 3B Unveils New Policy to Improve Quality of Care for the Low Income and Pennsylv 9904 4Governor Rendell Offers Coverage to 29 000 on AdultBasic Waiting List 3B Unveils New Policy to Improve Quality of Care for the Low Income and Pennsylv 9904 5Governor Rendell Offers Coverage to 29 000 on AdultBasic Waiting List 3B Unveils New Policy to Improve Quality of Care for the Low Income and Pennsylv 9904 6Governor Rendell Offers Coverage to 29 000 on AdultBasic Waiting List 3B Unveils New Policy to Improve Quality of Care for the Low Income and Pennsylv 9904 7U S Deaths Down From Heart Disease Stroke 9899 1U S Deaths Down From Heart Disease Stroke 9899 2U S Deaths Down From Heart Disease Stroke 9899 3Research and innovation at the intersection of physics and health sciences 9896 1Research and innovation at the intersection of physics and health sciences 9896 2
...earchers at SUNY Downstate Medical Center and the ...protein, PNC-28, is administered to pancreatic tum... research was reported in the October 1st edition ... R. Pincus, MD, PhD, professor of pathology at SUN...ry medicine at the Brooklyn VA, said, "The results...
...ew study on the ability of liver cells to interact...ulating the immune response) found that such inter... which they may take place. The results may help e...h aging and other conditions and may be useful in ...mmune diseases. , The results of this study appear...
... well an individual,s immune system controls HIV d...depend on both the specific versions of key immune...n inherited, as well as on the fragments of viral ...es that usually destroy infected cells. In a repo...hers from the Partners AIDS Research Center at Mas...
... lungs of patients suffering chronic obstructive p...elastic fibers, a new finding that contradicts the...ult lung. , The study "Evidence for attempted regi...s done by Jason Woods, Kristin Castillo, Alexander...sity, St. Louis, Mo.; Joel Cooper of the Universit...
Other Biology News:Encouraging results in pancreatic cancer research 2Interaction between lymph and liver cells may affect immune response 2Interaction between lymph and liver cells may affect immune response 3Early-stage immune system control of HIV may depend on inherited factors 2Early-stage immune system control of HIV may depend on inherited factors 3Lungs try to repair damaged elastic fibers 2
Used in May-Grunwald Giemsa stain.
Normal Bovine Serum; U.S. sourced, ideal for those who seek an uncompromising quality. Low Hemoglobin levels; U.S. sourced, ideal for those who seek an uncompromising quality. Low Hemoglobin lev
Bromphenol Blue, ACS Reagent from Research Organics, Inc.
GeneTailor Site-Directed Mutagenesis System from Invitrogen
Biology Products: